Michael Dacks

Michael Dacks

Founder at
Type 2 Ventures Ltd.
49 year
Process Industries
Consumer Services
Producer Manufacturing

Profile

Michael Dacks is the founder of Midatadin.com Ltd. (founded in 2013) and Type 2 Ventures Ltd. (founded in 2019).
He is currently the President & Chief Operating Officer at Psyence Therapeutics Corp.
(since 2020).
He previously held positions at Vertical Peak Holdings, Inc. as an Independent Director, MedReleaf Corp.
as VP-Legal & International Business Affair (2016-2018), Plena Global Holdings, Inc. as Senior Vice President-Global Affairs (2018-2019), StateHouse Holdings, Inc. as Director (2020-2021), and Psyence Group, Inc. as Chief Operating Officer (2020-2021).
Mr. Dacks received his undergraduate degree from the University of Western Ontario in 1998 and his graduate degree from Osgoode Hall Law School in 2004.

Michael Dacks active positions

CompaniesPositionStart
Type 2 Ventures Ltd.
Founder 31/03/2019
Psyence Therapeutics Corp.
President 31/07/2020

Former positions of Michael Dacks

CompaniesPositionEnd
STATEHOUSE HOLDINGS INC. Director/Board Member 30/12/2021
PSYENCE GROUP INC. Chief Operating Officer 31/01/2021
Corporate Officer/Principal 30/06/2019
MEDRELEAF CORP General Counsel 01/09/2018
Midatadin.com Ltd.
Founder 30/06/2016
See the detail of Michael Dacks's experience

Training of Michael Dacks

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Process Industries

Consumer Services

Consumer Services

Producer Manufacturing

Process Industries

Process Industries

Midatadin.com Ltd.

Industrial Services

Type 2 Ventures Ltd.

Psyence Therapeutics Corp.